Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

De-Escalation or Discontinuation of TKI in Patients with Chronic Myeloid Leukemia:a Multicentral,Open-Lable, Prospective Trial in China

Jie Luo, Yaxian Tan, Xuan Zhou, PhD, Liu Xiaoli, MD, Qifa Liu, MD, Na Xu

Blood (2020) 136 (Supplement 1): 6.

https://doi.org/10.1182/blood-2020-139413

Published: 2020

Journal Articles

Ruxolitinib during Allogeneic Stem Cell Transplantation (allo-SCT) in Primary Myelofibrosis (PMF) Recommendation

Yaxian Tan, Jie Luo, Xuan Zhou, PhD, Xiaoli Liu, Qifa Liu, MD, Na Xu

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-139410

Published: 2020

Journal Articles

A Survey of Survival Status of 601 Hemophilia Patients in Guangdong Region during COVID-19 Pandemic: Investigation and Implications

Lei Meng, Jing Sun, MD, Yufang Xun, Huiping Li, Zhuqin Liu, Xiaoqin Feng, Xuan Zhou, PhD

Blood (2020) 136 (Supplement 1): 21.

https://doi.org/10.1182/blood-2020-139241

Published: 2020

Journal Articles

The Change Regulation of Joint Structure and Function in Children with Severe Hemophilia a Receiving Low and Intermediate-Dose for Prophylaxis

Jinmu Zhuang, Xueyan Sun, Jingwen Guo, Xuan Zhou, PhD, Jieyu Ye, Jing Sun

Blood (2018) 132 (Supplement 1): 2463.

https://doi.org/10.1182/blood-2018-99-116230

Published: 2018

Journal Articles

Efficacy of Early Convert to Dasatinib in Chronic Myeloid Leukemia Patients Who Inresponse or Intolerance to Imatinib

Liu Liang, Na Xu, PhD, Xuan Zhou, PhD, Huang JiXian, Chen Chen, Lin Tong, Wu wan-Er, Changxin Yin, Qifa Liu, MD, Liu Xiaoli, MD

Blood (2018) 132 (Supplement 1): 5430.

https://doi.org/10.1182/blood-2018-99-114120

Published: 2018

Journal Articles

The Clinical Characteristics and Efficacy of Chronic Myeloid Leukemia Patients with T315I Mutation

Chen Chen, Na Xu, PhD, Wu WanEr, Liu Liang, Xuan Zhou, PhD, Huang JiXian, Yin Changxin, Rui Cao, Qifa Liu, MD, Liu Xiaoli, MD

Blood (2018) 132 (Supplement 1): 5433.

https://doi.org/10.1182/blood-2018-99-114113

Published: 2018

Journal Articles

PKM2 Mediates Chronic Myeloid Leukemia Imatinib Resistance By Regulating Glycolysis Energy Metabolism

Lin Tong, Na Xu, PhD, Xuan Zhou, PhD, Jixian Huang, Wu wan-Er, Chen Chen, Liu Liang, Qifa Liu, MD, Liu Xiaoli, MD

Blood (2018) 132 (Supplement 1): 1724.

https://doi.org/10.1182/blood-2018-99-113960

Published: 2018

Journal Articles

Inhibition of Atg7 Enhances Mesenchymal Stem Cells Regulates Energy Metabolism Coupling to Overcome Drug Resistance in Chronic Myeloid Leukemia

Na Xu, PhD, Yangqing Lan, Ziyuan Lu, PhD, Xuan Zhou, PhD, Jixian Huang, Bolin He, Jing Sun, MD, Liu Xiaoli, MD

Blood (2017) 130 (Supplement 1): 5244.

https://doi.org/10.1182/blood.V130.Suppl_1.5244.5244

Published: 2017

Journal Articles

Tumor-Derived LOXL2 Is Highly Expressed in Myelofibrosis and Activating Mesenchymal Stem Cells Differentiate into Cancer Associated Fibroblasts In Vitro

Na Xu, PhD, Chengyun Pan, Xuan Zhou, PhD, Jixian Huang, Yangqing Lan, Bolin He, Jing Sun, MD, Liu Xiaoli, MD

Blood (2017) 130 (Supplement 1): 5289.

https://doi.org/10.1182/blood.V130.Suppl_1.5289.5289

Published: 2017

Journal Articles

Infrared Thermal Imaging Maybe an Available Tool to Detect Arthrorrhagia in Patients with Hemophilia

Xuan Zhou, PhD, Xueyan Sun, Zhuqin Liu, Jinmu Zhuang, Jieyu Ye, Qifa Liu, MD, Jing Sun, MD

Blood (2017) 130 (Supplement 1): 4887.

https://doi.org/10.1182/blood.V130.Suppl_1.4887.4887

Published: 2017

Journal Articles

Characteristics and Effected Factors of Break-through Bleedings in Tertiary Prophylaxis with Low and Intermediate-Dose in Chinese Adults with Severe Hemophilia

Shiqiu Qiu, Jinmu Zhuang, Xuan Zhou, PhD, Ruixue Yin, Zhuqin Liu, Fei Ma, Yingjia Li, Jing Sun, MD

Blood (2017) 130 (Supplement 1): 4894.

https://doi.org/10.1182/blood.V130.Suppl_1.4894.4894

Published: 2017

Journal Articles

Tumor-Associated Macrophages Maybe Associated with Acute Myeloid Leukemia Survival and Prognosis

Xuan Zhou, PhD, Na Xu, PhD, Xueyan Sun, Tong Lin, Zhiping Fan, Rui Cao, Qifa Liu, MD, Jing Sun, MD, Liu Xiaoli, MD

Blood (2017) 130 (Supplement 1): 5090.

https://doi.org/10.1182/blood.V130.Suppl_1.5090.5090

Published: 2017

NARROW

De-Escalation or Discontinuation of TKI in Patients with Chronic Myeloid Leukemia:a Multicentral,Open-Lable, Prospective Trial in China

Ruxolitinib during Allogeneic Stem Cell Transplantation (allo-SCT) in Primary Myelofibrosis (PMF) Recommendation

A Survey of Survival Status of 601 Hemophilia Patients in Guangdong Region during COVID-19 Pandemic: Investigation and Implications

The Change Regulation of Joint Structure and Function in Children with Severe Hemophilia a Receiving Low and Intermediate-Dose for Prophylaxis

Efficacy of Early Convert to Dasatinib in Chronic Myeloid Leukemia Patients Who Inresponse or Intolerance to Imatinib

The Clinical Characteristics and Efficacy of Chronic Myeloid Leukemia Patients with T315I Mutation

PKM2 Mediates Chronic Myeloid Leukemia Imatinib Resistance By Regulating Glycolysis Energy Metabolism

Inhibition of Atg7 Enhances Mesenchymal Stem Cells Regulates Energy Metabolism Coupling to Overcome Drug Resistance in Chronic Myeloid Leukemia

Tumor-Derived LOXL2 Is Highly Expressed in Myelofibrosis and Activating Mesenchymal Stem Cells Differentiate into Cancer Associated Fibroblasts In Vitro

Infrared Thermal Imaging Maybe an Available Tool to Detect Arthrorrhagia in Patients with Hemophilia

Characteristics and Effected Factors of Break-through Bleedings in Tertiary Prophylaxis with Low and Intermediate-Dose in Chinese Adults with Severe Hemophilia

Tumor-Associated Macrophages Maybe Associated with Acute Myeloid Leukemia Survival and Prognosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only